Ifp Advisors, Inc Eli Lilly & CO Call Options Transaction History
Ifp Advisors, Inc
- $3.07 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding LLY
# of Institutions
4,376Shares Held
821MCall Options Held
9.97MPut Options Held
11.5M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$76.5 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$72.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.9 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.8 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.3MShares$25.9 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $718B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...